1. Home
  2. GKOS vs AXTA Comparison

GKOS vs AXTA Comparison

Compare GKOS & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$109.19

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Axalta Coating Systems Ltd.

AXTA

Axalta Coating Systems Ltd.

HOLD

Current Price

$30.89

Market Cap

6.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
AXTA
Founded
1998
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Paints/Coatings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.2B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
GKOS
AXTA
Price
$109.19
$30.89
Analyst Decision
Strong Buy
Buy
Analyst Count
13
14
Target Price
$123.62
$37.00
AVG Volume (30 Days)
846.3K
5.0M
Earning Date
10-29-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.67
EPS
N/A
2.09
Revenue
$469,820,000.00
$5,166,000,000.00
Revenue This Year
$31.15
N/A
Revenue Next Year
$24.15
$2.22
P/E Ratio
N/A
$14.78
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$26.28
52 Week High
$163.71
$39.19

Technical Indicators

Market Signals
Indicator
GKOS
AXTA
Relative Strength Index (RSI) 70.89 63.62
Support Level $105.88 $28.09
Resistance Level $110.87 $30.52
Average True Range (ATR) 3.39 0.81
MACD -0.04 0.10
Stochastic Oscillator 80.77 91.11

Price Performance

Historical Comparison
GKOS
AXTA

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.

Share on Social Networks: